Title | Type | SJR | H index | Total Docs. (2003) | Total Docs. (3years) | Total Refs. (2003) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2003) | %Female (2003) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
306 | Advances in Pharmacology | journal | 1.111 Q1 | 86 | 0 | 29 | 0 | 84 | 27 | 0.00 | 0.00 | 0.00 | |
305 | Adverse Drug Reactions and Toxicological Reviews | journal | 0.186 Q3 | 25 | 0 | 65 | 0 | 47 | 41 | 0.68 | 0.00 | 0.00 | |
304 | American Journal of PharmacoGenomics | journal | 0.619 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
303 | Antibiotics and chemotherapy | journal | 0.156 Q3 | 8 | 0 | 18 | 0 | 7 | 18 | 0.00 | 0.00 | 0.00 | |
302 | Anti-Cancer Drug Design | journal | 0.917 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
301 | Antiinfective Drugs and Chemotherapy | journal | 0.105 Q4 | 6 | 0 | 4 | 0 | 0 | 4 | 0.00 | 0.00 | 0.00 | |
300 | Antimicrobics and Infectious Diseases Newsletter | journal | 0.113 Q4 | 5 | 0 | 24 | 0 | 3 | 24 | 0.00 | 0.00 | 0.00 | |
299 | Antiviral Chemistry and Chemotherapy, Supplement | journal | 0.778 Q2 | 12 | 0 | 17 | 0 | 57 | 17 | 3.35 | 0.00 | 0.00 | |
298 | Current Issues in Pharmacy and Medical Sciences | journal | 0.102 Q4 | 13 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
297 | Current Opinion in Anti-inflammatory and Immunomodulatory Investigational Drugs | journal | 0.135 Q4 | 5 | 0 | 35 | 0 | 9 | 30 | 0.00 | 0.00 | 0.00 | |
296 | Current Protocols in Pharmacology | journal | 0.100 Q4 | 39 | 14 | 71 | 0 | 1 | 71 | 0.01 | 0.00 | 24.14 | |
295 | Current Therapeutics | journal | 0.102 Q4 | 5 | 0 | 358 | 0 | 9 | 281 | 0.03 | 0.00 | 0.00 | |
294 | Cytokines, Cellular and Molecular Therapy | journal | 0.421 Q2 | 28 | 0 | 50 | 0 | 48 | 50 | 0.19 | 0.00 | 0.00 | |
293 | Drugs Made in Germany | journal | 0.101 Q4 | 4 | 0 | 37 | 0 | 1 | 36 | 0.03 | 0.00 | 0.00 | |
292 | Gyogyszereszet | journal | 0.103 Q4 | 2 | 0 | 6 | 0 | 0 | 6 | 0.00 | 0.00 | 0.00 | |
291 | Hindustan Antibiotics Bulletin | journal | 0.102 Q4 | 10 | 8 | 11 | 0 | 0 | 11 | 0.00 | 0.00 | 25.00 | |
290 | Immunopharmacology | journal | 1.418 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
289 | International Antiviral News | journal | 0.307 Q3 | 8 | 0 | 48 | 0 | 27 | 38 | 0.08 | 0.00 | 0.00 | |
288 | International Journal of Immunopharmacology | journal | 0.563 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
287 | Japanese Journal of Pharmacology | journal | 0.425 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
286 | Japanese Journal of Psychopharmacology | journal | 0.203 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
285 | Journal of International Peacekeeping | journal | 0.101 Q4 | 14 | 0 | 58 | 0 | 0 | 48 | 0.00 | 0.00 | 0.00 | |
284 | Journal of Managed Pharmaceutical Care | journal | 0.115 Q4 | 3 | 0 | 35 | 0 | 3 | 34 | 0.09 | 0.00 | 0.00 | |
283 | Journal of Pharmacological and Toxicological Methods | journal | 0.408 Q3 | 83 | 0 | 155 | 0 | 227 | 150 | 0.66 | 0.00 | 0.00 | |
282 | Medical Letter on Drugs and Therapeutics | journal | 0.379 Q3 | 22 | 61 | 181 | 0 | 134 | 181 | 0.69 | 0.00 | 0.00 | |
281 | Metal-Based Drugs | journal | 0.250 Q3 | 40 | 0 | 107 | 0 | 79 | 106 | 0.63 | 0.00 | 0.00 | |
280 | National Toxicology Program technical report series | journal | 0.101 | 22 | 3 | 13 | 0 | 1 | 13 | 0.00 | 0.00 | 0.00 | |
279 | Neuropsychopharmacology Reports | journal | 22 | 1 | 96 | 0 | 38 | 91 | 0.43 | 0.00 | 0.00 | ||
278 | Perspectives in Drug Discovery and Design | journal | 0.730 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
277 | Pharmaceutical and Pharmacological Letters | journal | 0.194 Q3 | 18 | 0 | 51 | 0 | 18 | 50 | 0.37 | 0.00 | 0.00 | |
276 | Pharmacochemistry Library | journal | 0.106 Q4 | 10 | 0 | 43 | 0 | 5 | 39 | 0.16 | 0.00 | 0.00 | |
275 | Pharmacology and Toxicology, Supplement | journal | 0.155 Q3 | 7 | 0 | 10 | 0 | 3 | 9 | 0.00 | 0.00 | 0.00 | |
274 | Pharmacology Reviews and Communications | journal | 0.104 Q4 | 9 | 0 | 60 | 0 | 8 | 60 | 0.14 | 0.00 | 0.00 | |
273 | Pharmacy and Pharmacology Communications | journal | 0.185 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
272 | Revista Cubana de Farmacia | journal | 0.101 Q4 | 10 | 0 | 24 | 0 | 0 | 24 | 0.00 | 0.00 | 0.00 | |
271 | Revista Cubana de Plantas Medicinales | journal | 0.100 Q4 | 16 | 0 | 64 | 0 | 0 | 64 | 0.00 | 0.00 | 0.00 | |
270 | Therapiewoche | journal | 0.100 Q4 | 1 | 0 | 94 | 0 | 0 | 81 | 0.00 | 0.00 | 0.00 | |
269 | Therapiewoche Schweiz | journal | 0.101 Q4 | 1 | 0 | 15 | 0 | 0 | 15 | 0.00 | 0.00 | 0.00 | |
268 | Drug Topics | journal | 0.107 Q4 | 8 | 461 | 1090 | 4 | 37 | 781 | 0.03 | 0.01 | 52.00 | |
267 | Current Drug Discovery | journal | 0.127 Q4 | 13 | 130 | 174 | 17 | 30 | 110 | 0.17 | 0.13 | 20.00 | |
266 | European Journal of Herbal Medicine | journal | 0.102 Q4 | 3 | 3 | 20 | 20 | 2 | 12 | 0.10 | 6.67 | 0.00 | |
265 | Journal of Clinical Research | journal | 0.229 Q3 | 12 | 2 | 18 | 27 | 21 | 18 | 1.33 | 13.50 | 0.00 | |
264 | Annual Report of Shionogi Research Laboratory | journal | 0.105 Q4 | 2 | 1 | 4 | 64 | 0 | 4 | 0.00 | 64.00 | 100.00 | |
263 | Pharmaca | journal | 0.124 Q4 | 5 | 3 | 27 | 128 | 3 | 27 | 0.14 | 42.67 | 25.00 | |
262 | Journal of Immune Based Therapies and Vaccines | journal | 21 | 5 | 0 | 135 | 0 | 0 | 0.00 | 27.00 | 32.00 | ||
261 | Acta Physiologica et Pharmacologica Bulgarica | journal | 0.174 Q3 | 16 | 12 | 59 | 142 | 20 | 59 | 0.36 | 11.83 | 47.06 | |
260 | Circular Farmaceutica | journal | 0.100 Q4 | 3 | 40 | 101 | 143 | 0 | 90 | 0.00 | 3.58 | 37.50 | |
259 | Chemotherapie Journal, Supplement | journal | 0.114 Q4 | 6 | 6 | 40 | 148 | 10 | 39 | 0.22 | 24.67 | 25.00 | |
258 | Farmaceutisch Tijdschrift voor Belgie | journal | 0.100 Q4 | 3 | 13 | 43 | 151 | 0 | 40 | 0.00 | 11.62 | 62.50 | |
257 | BMC Clinical Pharmacology | journal | 0.336 Q3 | 43 | 4 | 12 | 156 | 16 | 12 | 1.33 | 39.00 | 11.11 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®